Medicare Enrolled

Sara Castantini, FNP-BC

Nurse Practitioner - Family · Danvers, MA
140 COMMONWEALTH AVE, Danvers, MA 01923
9787626262
Registered in NPPES since 2015
NPI: 1477929610 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Castantini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Castantini? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Castantini

Sara Castantini is a nurse practitioner - family in Danvers, MA, with 11 years of NPI registration.

Between the years covered by Open Payments, Castantini received a total of $3,251 from 37 pharmaceutical and/or device companies across 170 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Castantini is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years of NPI registration $3,251 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$3,251
Total received (2021-2024)
Avg $813/year across 4 years
Top 6% in MA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
170
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$685
2023
$415
2022
$1,177
2021
$974

Payments by company (2024)

ABBVIE INC.
$108
AstraZeneca Pharmaceuticals LP
$108
Novartis Pharmaceuticals Corporation
$99
Novo Nordisk Inc
$64
Lilly USA, LLC
$51
Exact Sciences Corporation
$47
Philips North America LLC
$31
Medtronic, Inc.
$25
Janssen Pharmaceuticals, Inc
$22
Lundbeck LLC
$21
Lexicon Pharmaceuticals, Inc.
$21
Lucid Diagnostics Inc.
$19
Alkermes, Inc.
$19
Corium, LLC
$18
Mylan Specialty L.P.
$17
Ardelyx, Inc.
$15
Top 3 companies account for 46.1% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$420
Novo Nordisk Inc
$401
AstraZeneca Pharmaceuticals LP
$300
PFIZER INC.
$254
Novartis Pharmaceuticals Corporation
$175
Boehringer Ingelheim Pharmaceuticals, Inc.
$168
Lilly USA, LLC
$165
Astellas Pharma US Inc
$145
Mylan Specialty L.P.
$142
Takeda Pharmaceuticals U.S.A., Inc.
$142
AbbVie Inc.
$108
GlaxoSmithKline, LLC.
$95
Amgen Inc.
$80
Corium, LLC
$61
Bayer HealthCare Pharmaceuticals Inc.
$58
Exact Sciences Corporation
$47
Teva Pharmaceuticals USA, Inc.
$44
Lundbeck LLC
$39
Otsuka America Pharmaceutical, Inc.
$38
Merck Sharp & Dohme Corporation
$34
Philips North America LLC
$31
Medtronic, Inc.
$25
ITI, Inc.
$24
Janssen Pharmaceuticals, Inc
$22
Phadia US Inc.
$21
Lexicon Pharmaceuticals, Inc.
$21
Ultragenyx Pharmaceutical Inc.
$20
Lucid Diagnostics Inc.
$19
Antares Pharma, Inc.
$19
Alkermes, Inc.
$19
Eisai Inc.
$18
IDORSIA PHARMACEUTICALS US INC
$18
Neos Therapeutics, LP
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Merck Sharp & Dohme LLC
$15
Ardelyx, Inc.
$15
Top 3 companies account for 34.5% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · ANORO ELLIPTA · AZSTARYS · Adzenys XR-ODT · ArmonAir Digihaler · Azstarys · BREZTRI · CAPLYTA · Cologuard Collection Kit · DALVANCE · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · FASENRA · GARDASIL 9 · IBSRELA · ImmunoCAP · JARDIANCE · Kerendia · LEQVIO · MOUNJARO · MYRBETRIQ · Myrbetriq · NOCDURNA · OFEV · Otezla · Ozempic · PREVNAR 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SPIRIVA RESPIMAT · SYMBICORT · Saxenda · TEFLARO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · UBRELVY · VENASEAL · VIVITROL · VRAYLAR · Wegovy · XARELTO · XIFAXAN · YUPELRI · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - family in Danvers?
Compare family nurse practitioners in the Danvers area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners in nearby ZIP areas
2,155
County median income
$99,431
Nearest hospital to ZIP centroid (approximate)
NORTHEAST HOSPITAL CORPORATION
4.2 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Castantini is a nurse practitioner - family.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Castantini receive payments from pharmaceutical companies?
Yes. Castantini received a total of $3,251 from 37 companies across 170 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Castantini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Family Nurse Practitioners in Danvers
Browse family nurse practitioners in Danvers ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in MA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in MA
Which MA family nurse practitioners receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →